Market Overview

UPDATE: Bank of America Reiterates on Aviv REIT Following Mixed 4Q Results

Aviv REIT Announces Special Meeting Date
Stifel Downgrades Aviv REIT After Exceeding Price Target

In a report published Thursday, Bank of America analyst Juan C. Sanabria reiterated an Underweight rating on Aviv REIT (NYSE: AVIV), and raised the price target from $23.00 to $23.50.

In the report, Bank of America noted, “Within our coverage, healthcare REIT earnings results were mixed. HCN, HCP & NHI exceeded; AVIV, SNH & VTR met; and MPW missed. AVIV, HCN, HCP, MPW & NHI all initiated 2014 guidance below Street expectations due largely to the exclusion of future acquisitions in company forecasts. VTR was the only REIT that initiated guidance in line with expectations. SNH does not provide guidance. Specifically, VTR initiated same store (SS) cash NOI growth guidance of 3-4% across its portfolio, and is expecting SS RIDEA growth of 4-6%. HCN is expecting 3-3.5% overall SS cash NOI growth with RIDEA 5% or greater. HCP is forecasting 3-4% overall cash SS NOI growth with senior housing at 3.5-4.5%.”

Aviv REIT closed on Wednesday at $25.69.

Latest Ratings for AVIV

Feb 2015CitigroupMaintainsNeutral
Nov 2014RBC CapitalDowngradesOutperformSector Perform
Nov 2014StifelDowngradesBuyHold

View More Analyst Ratings for AVIV
View the Latest Analyst Ratings

Posted-In: Bank of America Juan C. SanabriaAnalyst Color Price Target Analyst Ratings


Related Articles (AVIV)

View Comments and Join the Discussion!

Partner Center